List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 15 studies with search of:   "Chordoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Identifying New Families With Multiple Members Affected by Chordoma
Condition: Chordoma
Interventions: Procedure: DNA analysis;   Procedure: cytology specimen collection procedure;   Procedure: medical chart review;   Procedure: questionnaire administration
2 Completed Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
Condition: Chordoma
Intervention:
3 Recruiting Proton Beam Therapy for Chordoma Patients
Condition: Chordoma
Interventions: Radiation: Proton Beam Therapy;   Radiation: Proton Beam Therapy
4 Completed Efficacy and Safety of Imatinib in Chordoma
Condition: Chordoma
Intervention: Drug: imatinib
5 Recruiting Proton Therapy for Chordomas and/or Chondrosarcomas Outcomes Protocol
Conditions: Chordomas;   Chondrosarcomas
Intervention: Radiation: Proton beam radiation therapy
6 Recruiting Hypoxia-Positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Condition: Chordoma
Intervention: Procedure: Fluoromisonidazole-PET/CT
7 Active, not recruiting Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Conditions: Chordoma;   Chondrosarcoma
Intervention: Radiation: Charged Particle Radiation Therapy
8 Recruiting Study of Individuals and Families at High Risk for Cancer
Conditions: Bladder Cancer;   Brain and Central Nervous System Tumors;   Chordoma;   Lung Cancer;   Non-Melanomatous Skin Cancer;   Retinoblastoma;   Sarcoma
Interventions: Procedure: comparative genomic hybridization;   Procedure: gene rearrangement analysis;   Procedure: genetic linkage analysis;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: questionnaire administration
9 Recruiting Trial of Dasatinib in Advanced Sarcomas
Conditions: MFH/Pleomorphic Undifferentiated Sarcoma;   Rhabdomyosarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Osteosarcoma;   Chondrosarcoma;   Sarcoma, Ewing's;   Sarcoma, Alveolar Soft Part;   Chordoma;   Epithelioid Sarcoma;   Giant Cell Tumor of Bone;   Hemangiopericytoma;   Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: Dasatinib
10 Recruiting Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
Conditions: Brain and Central Nervous System Tumors;   Chordoma;   Lymphoma;   Von Hippel-Lindau Syndrome
Interventions: Drug: mannitol;   Drug: melphalan
11 Recruiting Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition;   Chordoma;   Kidney Cancer;   Leukemia;   Lymphoma;   Neuroblastoma;   Pain;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: polyvinylpyrrolidone-sodium hyaluronate gel
12 Terminated Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition;   Childhood Germ Cell Tumor;   Chordoma;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Testicular Germ Cell Tumor
Interventions: Drug: amifostine trihydrate;   Drug: busulfan;   Drug: filgrastim;   Drug: melphalan;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation
13 Recruiting Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health
Conditions: Brain and Central Nervous System Tumors;   Chordoma;   Neuroblastoma
Intervention: Procedure: physiologic testing
14 Recruiting 1-Methyl-d-Tryptophan in Treating Patients With Relapsed or Refractory Solid Tumors
Condition: Cancer
Interventions: Drug: 1-methyl-d-tryptophan;   Procedure: flow cytometry;   Procedure: fluorescence activated cell sorting;   Procedure: high performance liquid chromatography;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study
15 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services